Literature DB >> 8001114

Transcriptional control points during lymphopoiesis.

K Dorshkind1.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 8001114     DOI: 10.1016/0092-8674(94)90065-5

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  7 in total

1.  Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice.

Authors:  Q Ma; D Jones; P R Borghesani; R A Segal; T Nagasawa; T Kishimoto; R T Bronson; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

2.  Role of the PAS domain in regulation of dimerization and DNA binding specificity of the dioxin receptor.

Authors:  I Pongratz; C Antonsson; M L Whitelaw; L Poellinger
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

3.  E47 activates the Ig-heavy chain and TdT loci in non-B cells.

Authors:  J K Choi; C P Shen; H S Radomska; L A Eckhardt; T Kadesch
Journal:  EMBO J       Date:  1996-09-16       Impact factor: 11.598

4.  A potential role for Elf-1 in terminal transferase gene regulation.

Authors:  P Ernst; K Hahm; L Trinh; J N Davis; M F Roussel; C W Turck; S T Smale
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

5.  Regulation of the pro-B-cell-specific enhancer of the Id1 gene involves the C/EBP family of proteins.

Authors:  S Saisanit; X H Sun
Journal:  Mol Cell Biol       Date:  1997-02       Impact factor: 4.272

6.  A human non-XLA immunodeficiency disease characterized by blockage of B cell development at an early proB cell stage.

Authors:  E Meffre; F LeDeist; G de Saint-Basile; A Deville; M Fougereau; A Fischer; C Schiff
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

7.  Molecular and cellular analysis of B-cell populations in the rainbow trout using Pax5 and immunoglobulin markers.

Authors:  Patty Zwollo; Ashley Haines; Pam Rosato; Juliann Gumulak-Smith
Journal:  Dev Comp Immunol       Date:  2008-07-09       Impact factor: 3.636

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.